Mumbai, Oct. 1 -- According to bulk deal data for 30 September 2026, HDFC Mutual Fund bought 23 lakh shares, representing a 2% stake in Molbio Diagnostics, at Rs 1,315 per share.

Business Excellence Trust III sold 23,28,996 shares, equivalent to a 2.02% stake, at Rs 1,315.01 per share. It held an 11.52% stake in the company as of 14 August 2026.

Goa-based Molbio Diagnostics is a point-of-care diagnostics company focused testing for infectious and non-communicable diseases. Its flagship Truenat platform is a portable, battery-operated real-time PCR system that enables decentralised molecular testing, with results available in about an hour. Truenat is patented in more than 100 countries and supports testing for 30 diseases through 43 ass...